For the quarter ending 2026-03-31, MGRX has $14,449,223 in assets. $974,571 in debts. $174,562 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 174,562 | 1,486,338 | 481,281 | 101,019 |
| Prepaid expenses | 897 | 7,021 | 100,000 | - |
| Prepaid expenses-Related Party | - | 120 | - | - |
| Deposits | 16,957 | 33,899 | 16,942 | 16,942 |
| Due from related party | 20,056 | 20,056 | - | - |
| Total current assets | 212,472 | 1,547,434 | 598,223 | 117,961 |
| Property and equipment, net of accumulated depreciation of 3,518 and 3,268 | 1,544 | 1,794 | 2,049 | 2,304 |
| Operating lease right-of-use assets | 294,061 | 307,861 | 11,211 | 27,670 |
| Intangible assets - acquired patents and license, net of amortization | 13,941,146 | 14,232,484 | 15,920,319 | 20,694,893 |
| Total non-current assets | 14,236,751 | 14,542,139 | 15,933,579 | 20,724,867 |
| Total assets | 14,449,223 | 16,089,573 | 16,531,802 | 20,842,828 |
| Accounts payable and accrued liabilities | 529,800 | 416,682 | 526,964 | 767,996 |
| Accrued liabilities - related parties | - | - | - | 30,000 |
| Payroll tax liabilities | 3,297 | 9,421 | 4,460 | 2,973 |
| Notes payable-Nonrelated Party | - | - | - | 500,000 |
| Notes payable-Related Party | - | - | 100,000 | 100,000 |
| Operating lease liability, current | 57,058 | 307,823 | 12,167 | 30,117 |
| Other liabilities | 147,451 | 156,642 | 160,684 | 160,684 |
| Other liabilities-Related Party | - | - | - | 9,175 |
| Total current liabilities | 737,606 | 890,568 | 804,275 | 1,600,945 |
| Operating lease liability, net of current portion | 236,965 | - | - | - |
| Total long-term liabilities | 236,965 | - | - | - |
| Total liabilities | 974,571 | 890,568 | 804,275 | 1,600,945 |
| Preferred stock, value | 98 | 98 | 98 | 98 |
| Common stock (par value 0.0001), 200,000,000 shares authorized, of which 16,967,421 and 15,888,795 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 1,698 | 1,589 | 1,389 | 1,065 |
| Stock warrants | 324,288 | 324,288 | 324,288 | 324,288 |
| Subscriptions receivable | - | - | - | 224,569 |
| Additional paid in capital | 57,203,924 | 55,524,812 | 53,283,483 | 50,794,020 |
| Accumulated deficit | -44,050,630 | -40,647,480 | -37,877,913 | -31,649,804 |
| Accumulated other comprehensive loss | -3,193 | -2,760 | -2,079 | -2,034 |
| Total mangoceuticals, inc. stockholders equity | 13,476,185 | 15,200,547 | 15,729,266 | 19,243,064 |
| Non-controlling interest | -1,533 | -1,542 | -1,739 | -1,181 |
| Total stockholders equity | 13,474,652 | 15,199,005 | 15,727,527 | 19,241,883 |
| Total liabilities and stockholders equity | 14,449,223 | 16,089,573 | 16,531,802 | 20,842,828 |
MANGOCEUTICALS, INC. (MGRX)
MANGOCEUTICALS, INC. (MGRX)